Responses
Diabetes and endocrinology
Protocol
Efficacy of calcium dobesilate in treating Chinese patients with mild-to-moderate non-proliferative diabetic retinopathy (CALM-DR): protocol for a single-blind, multicentre, 24-armed cluster-randomised, controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.